1. Tefferi A, Gotlib J, Pardanani A . Hypereosinophilic syndrome and clonal eosinophilia: point-of-care diagnostic algorithm and treatment update. Mayo Clin Proc 2010; 85: 158–164.
2. Bain BJ, Gilliland DG, Horny HP, Vardiman JW Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al (eds) WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues, 4th edn. International Agency for Research and Cancer (IARC): Lyon, France, 2008, pp 68–73.
3. Bain BJ, Gilliland DG, Vardiman JW, Horny HP . Chronic eosinophilic leuekaemia, not otherwise specified. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al (eds) WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues. International agency for research on cancer (IARC): Lyon, France, 2008, pp 51–53.
4. Cogan E, Schandene L, Crusiaux A, Cochaux P, Velu T, Goldman M . Brief report: clonal proliferation of type 2 helper T cells in a man with the hypereosinophilic syndrome. N Engl J Med 1994; 330: 535–538.
5. Valent P, Klion AD, Horny HP, Roufosse F, Gotlib J, Weller PF et al. Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes. J Allergy Clin Immunol 2012; 130: 607–612 e9.